FDA Issues Warning on Dangerous Contaminated Tattoo Inks

The FDA warns about two tattoo inks contaminated with bacteria that can cause serious infections. Consumers and artists should be cautious and check ink sources to ensure safety.
The U.S. Food and Drug Administration (FDA) has issued a warning to both consumers and tattoo artists regarding the safety of certain tattoo inks. Recent testing revealed that two specific inks, Sacred Tattoo Ink in Raven Black and Sunny Daze, were contaminated with harmful bacteria, including Pseudomonas aeruginosa, which poses a risk of serious infections when injected into the skin.
The contaminated products are identified by their lot numbers and expiration dates: Raven Black (Lot RB0624, Best Before June 28, 2027) and Sunny Daze (Lot SD1124, Best Before Nov 1, 2027). Infection symptoms can include redness, rashes, bumps, or lesions that might lead to permanent scarring if not treated promptly. The FDA highlights that breaking the skin barrier during tattooing increases the risk of infection, which can sometimes be mistaken for allergic reactions, potentially delaying appropriate treatment.
These findings stem from routine microbiological testing used primarily for cosmetics, during which the FDA discovered the bacterial contamination. As a precaution, tattoo artists and studios are advised to avoid using or selling these specific inks. Consumers are encouraged to inquire about ink brands used during tattoo sessions and opt for reputable, verified products.
The FDA is actively working with manufacturers and vendors to remove these contaminated inks from the market. Anyone experiencing adverse reactions after getting a tattoo should seek medical attention and report their experiences via the FDA’s SmartHub platform. For more details on tattoo safety, visit the FDA's dedicated page on tattoo health concerns.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Early Microbiome Composition in Infants Might Protect Against Childhood Viral Infections
Emerging research shows that the gut microbiome of newborns, especially within the first week, may help protect children against viral respiratory infections, paving the way for microbiome-based preventive strategies.
Recovery of Health Care Job Growth Post-Pandemic Reaches Pre-2020 Levels by 2024
Despite initial declines during the COVID-19 pandemic, healthcare employment fully recovered by 2024, surpassing pre-pandemic levels, according to recent research.
Urine-based Tumor DNA Testing Enhances Personalization of Bladder Cancer Treatment
A new urine-based tumor DNA test shows promise in predicting treatment response and recurrence risk in bladder cancer, enabling more personalized and less invasive management strategies.
Orforglipron Oral Medication Shows Promising Weight Loss Results in Obese Patients
A new study reveals that daily oral administration of orforglipron leads to significant weight loss in obese individuals without diabetes, offering a promising alternative to injectable treatments.



